GLP-1-mediated delivery of the PPAR𝛼/𝛾 dual-agonist Tesaglitazar improves obesity and glucose metabolism in mice
Carmelo Quarta(Université de Bordeaux), Timo D. Müller(Anton Paar (Austria)), Gustav Colldén(Inserm), Aimée Bastidas-Ponce(Universidad Nacional Autónoma de México), Diego Pérez–Tilve(University of Cincinnati Medical Center), Fanny Lalloyer(Inserm), Nathalie Hennuyer(Inserm), Alexandra Harger(University of Graz), Susanna M. Hofmann(Helmholtz Zentrum München), Felix Klingelhuber(Deutsches Diabetes-Zentrum e.V.), Gandhari Maity(Helmholtz Zentrum München), Aaron Novikoff(Deutsches Diabetes-Zentrum e.V.), Brian Finan(Eli Lilly (United States)), Daniel J. Drucker(University of Toronto), Cristina García‐Cáceres(Helmholtz Zentrum München), Eric Baugé(Inserm), Heiko Lickert(Helmholtz Zentrum München), Perla Cota(Deutsches Diabetes-Zentrum e.V.), Bin Yang, Kerstin Stemmer(University of Augsburg), Konxhe Kulaj(Helmholtz Zentrum München), Richard D. DiMarchi(Indiana University Bloomington), Stephan Herzig(Heidelberg University), Natalie Krahmer(Helmholtz Zentrum München), Mostafa Bakhti(Helmholtz Zentrum München), Gerald Grandl(Helmholtz Zentrum München), Christoffer Clemmensen(University of Copenhagen), Qian Zhang(Jiangsu Academy of Agricultural Sciences), Matthias Tschoep(Helmholtz Zentrum München), Bard Staels(Institut Pasteur de Lille), Miguel A. Sánchez-Garrido(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 0
Related Papers
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k
Anti-obesity drug discovery: advances and challenges
|Nature Reviews Drug Discovery|2021|950
A guide to analysis of mouse energy metabolism
|Nature Methods|2011|816
The role of gut hormones in glucose homeostasis
|Journal of Clinical Investigation|2007|611
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602